Salarius Pharmaceuticals Inc (SLRX)
2.38
-0.07
(-2.86%)
USD |
NASDAQ |
Jun 28, 16:00
2.04
-0.34
(-14.29%)
After-Hours: 20:00
Salarius Pharmaceuticals Shareholders Equity (Quarterly): 3.650M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.650M |
| December 31, 2023 | 5.287M |
| September 30, 2023 | 6.084M |
| June 30, 2023 | 8.414M |
| March 31, 2023 | 5.559M |
| December 31, 2022 | 10.38M |
| September 30, 2022 | 16.61M |
| June 30, 2022 | 30.88M |
| March 31, 2022 | 33.42M |
| December 31, 2021 | 38.72M |
| September 30, 2021 | 42.65M |
| June 30, 2021 | 45.85M |
| March 31, 2021 | 48.78M |
| December 31, 2020 | 22.16M |
| September 30, 2020 | 20.61M |
| June 30, 2020 | 16.86M |
| March 31, 2020 | 18.00M |
| December 31, 2019 | 10.58M |
| September 30, 2019 | 9.737M |
| Date | Value |
|---|---|
| June 30, 2019 | 6.101M |
| March 31, 2019 | 7.273M |
| December 31, 2018 | 9.283M |
| September 30, 2018 | 11.05M |
| June 30, 2018 | 13.41M |
| March 31, 2018 | 21.89M |
| December 31, 2017 | 29.11M |
| September 30, 2017 | 36.18M |
| June 30, 2017 | 44.50M |
| March 31, 2017 | 52.23M |
| December 31, 2016 | 59.32M |
| September 30, 2016 | 66.03M |
| June 30, 2016 | 74.82M |
| March 31, 2016 | 84.17M |
| December 31, 2015 | 92.19M |
| September 30, 2015 | 98.00M |
| June 30, 2015 | 104.65M |
| March 31, 2015 | 110.08M |
| September 30, 2014 | 35.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.650M
Minimum
Mar 2024
48.78M
Maximum
Mar 2021
20.02M
Average
16.73M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.884M |
| Total Liabilities (Quarterly) | 1.234M |